title: Testicular toxicity in F344 rats by aminophenylnorharman, formed from norharman and aniline.
abstract: 9-(4'-Aminophenyl)-9H-pyrido[3,4-b]indole [aminophenylnorharman (APNH)] is a novel mutagenic heterocyclic amine, produced by the reaction of norharman with aniline in the presence of S9 mix. In the present study, the acute toxicity of this compound was investigated in male F344 rats. Ten-week-old animals were treated with a single intragastric injection of APNH at doses of 45 or 90 mg/kg body wt and euthanized 1, 3, or 6 days afterward. When APNH was administered at a dose of 90 mg/kg, vacuolation of Sertoli cells in the testis was seen at 1 day after treatment. The testicular damage had markedly progressed by day 6, with multinucleated giant cells and loss of round spermatids in the seminiferous tubules observed in groups 1 and 2 of the four histological categories of spermatogenesis. Numbers of spermatogonia were also decreased by APNH treatment. No toxic changes were observed in Leydig cells under these conditions and serum follicle-stimulating hormone and luteinizing hormone concentrations were also unchanged from control values. Such severe testicular damage was not observed at any time point at the 45 mg/kg dose level of APNH. Moreover, neither norharman nor aniline alone exerted acute testicular toxicity at doses equivalent to 90 mg/kg of APNH. In addition to the testicular lesions, erosive changes of urinary bladder, thymic atrophy, and panmyelophthisis were evident in rats given APNH at 90 mg/kg.
authors.affiliation: Cancer Prevention Division, National Cancer Center Research Institute, 1-1 Tsukiji 5-chome, Tokyo, Chuo-ku, 104-0045, Japan. ytotsuka@gan2.ncc.go.jp
authors.forename: Y
authors.initials: Y
authors.lastname: Totsuka
authors.forename: T
authors.initials: T
authors.lastname: Kawamori
authors.forename: S
authors.initials: S
authors.lastname: Hisada
authors.forename: K
authors.initials: K
authors.lastname: Mitsumori
authors.forename: J
authors.initials: J
authors.lastname: Ishihara
authors.forename: T
authors.initials: T
authors.lastname: Sugimura
authors.forename: K
authors.initials: K
authors.lastname: Wakabayashi
mesh_terms: D000284:Administration, Oral; D000814:Aniline Compounds / Q000633:toxicity; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D002243:Carbolines; D002273:Carcinogens / Q000633:toxicity*; D005640:Follicle Stimulating Hormone / Q000097:blood; D006247:Harmine / Q000031:analogs & derivatives / Q000633:toxicity; D007211:Indoles / Q000633:toxicity*; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D009153:Mutagens / Q000633:toxicity; D009929:Organ Size / Q000187:drug effects; D011725:Pyridines / Q000633:toxicity*; D051381:Rats; D011916:Rats, Inbred F344; D012671:Seminiferous Tubules / Q000473:pathology; D013737:Testis / Q000187:drug effects*
chemical_list: D000814:Aniline Compounds; D002243:Carbolines; D002273:Carcinogens; D007211:Indoles; D009153:Mutagens; D011725:Pyridines; D006247:Harmine; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; C010262:norharman; C421010:9-(4'-aminophenyl)-9H-pyrido(3,4-b)indole; C023650:aniline